BGI-Shenzhen extends tender offer for Complete Genomics

theflyonthewall.com

BGI-Shenzhen announced that it, through its wholly owned subsidiary Beta Acquisition, has extended its all cash tender offer to purchase all outstanding shares of common stock of Complete Genomics to 12:00 midnight on Friday, January 11.

Rates

View Comments (0)